BIOGEN INC. Income (Loss) from Equity Method Investments
BIOGEN INC. (BIIB) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-12.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2025-02-12
- BIOGEN INC. income (loss) from equity method investments for the quarter ending 2023-12-31 was $0.00.
- BIOGEN INC. income (loss) from equity method investments for the quarter ending 2023-09-30 was $0.00.
- BIOGEN INC. income (loss) from equity method investments for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. income (loss) from equity method investments for the quarter ending 2023-03-31 was $0.00.
- BIOGEN INC. income (loss) from equity method investments for fiscal 2024 was $0.00.
- BIOGEN INC. income (loss) from equity method investments for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIOGEN INC. income (loss) from equity method investments for fiscal 2022 was $2.60M, a 92.55% decline from fiscal 2021.
- BIOGEN INC. income (loss) from equity method investments for fiscal 2021 was $34.90M, a 957.58% increase from fiscal 2020.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 3 month as first filed | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-12 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $0.00 derived: sum of 3 quarters · filed 2025-02-12 | $0.00 10-K · filed 2025-02-12 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $0.00 10-Q · filed 2023-07-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-12 | $0.00 derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-04-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $0.00 derived: sum of 3 quarters · filed 2025-02-12 | $5.90M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $5.90M derived: sum of 3 quarters · filed 2025-02-12 | $2.60M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.90M derived: sum of 2 quarters · filed 2023-11-08 | $2.60M 10-Q · filed 2023-11-08 | $20.30M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $2.60M 10-Q · filed 2023-07-25 | $20.30M derived: sum of 3 quarters · filed 2024-02-14 | $21.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$3.30M 10-Q · filed 2023-04-25 | $14.40M derived: sum of 2 quarters · filed 2024-02-14 | $15.50M derived: sum of 3 quarters · filed 2024-02-14 | $49.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $18.80M derived: sum of 2 quarters · filed 2024-02-14 | $53.10M derived: sum of 3 quarters · filed 2024-02-14 | $34.90M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $35.40M derived: sum of 2 quarters · filed 2022-10-25 | $17.20M 10-Q · filed 2022-10-25 | $35.20M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $34.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $16.10M 10-Q · filed 2022-07-20 | $34.10M derived: sum of 3 quarters · filed 2023-02-15 | $21.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$18.20M 10-Q · filed 2022-05-03 | -$200.00K derived: sum of 2 quarters · filed 2023-02-15 | -$13.30M derived: sum of 3 quarters · filed 2023-02-15 | $1.80M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $4.90M derived: sum of 2 quarters · filed 2023-02-15 | $20.00M derived: sum of 3 quarters · filed 2023-02-15 | $3.30M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | -$13.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $2.00M derived: sum of 2 quarters · filed 2021-10-20 | -$14.70M 10-Q · filed 2021-10-20 | $14.70M 10-Q · filed 2020-10-21 | -$155.70M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-06-30 | $15.10M 10-Q · filed 2020-07-22 | -$1.60M 10-Q · filed 2021-07-22 | $400.00K 10-Q · filed 2020-07-22 | -$142.60M derived: sum of 3 quarters · filed 2022-02-03 | -$164.40M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-03-31 | -$16.80M 10-Q · filed 2021-04-22 | -$14.80M 10-Q · filed 2020-04-23 | -$157.70M derived: sum of 2 quarters · filed 2022-02-03 | -$179.50M derived: sum of 3 quarters · filed 2022-02-03 | -$195.80M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2019-12-31 | -$140.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$162.70M derived: sum of 2 quarters · filed 2022-02-03 | -$179.00M derived: sum of 3 quarters · filed 2022-02-03 | -$77.40M 10-K · filed 2022-02-03 | -$79.40M 10-K · filed 2020-02-06 | |||
| 2019-09-30 | -$21.80M 10-Q · filed 2019-10-22 | -$38.10M derived: sum of 2 quarters · filed 2020-07-22 | $63.50M 10-Q · filed 2020-10-21 | -$66.80M 10-Q · filed 2019-10-22 | -$66.80M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-06-30 | -$16.30M 10-Q · filed 2020-07-22 | -$45.00M 10-Q · filed 2020-07-22 | -$45.00M derived: sum of 3 quarters · filed 2021-02-03 | -$45.00M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$28.70M 10-Q · filed 2020-04-23 | -$28.70M derived: sum of 2 quarters · filed 2021-02-03 | -$28.70M derived: sum of 3 quarters · filed 2021-02-03 | -$28.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $0.00 derived: sum of 2 quarters · filed 2021-02-03 | $0.00 derived: sum of 3 quarters · filed 2021-02-03 | $0.00 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-22 | $0.00 derived: sum of 2 quarters · filed 2019-10-22 | $0.00 10-Q · filed 2019-10-22 | $0.00 derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 | $0.00 10-Q · filed 2019-07-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-06 | $0.00 derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-06 | $0.00 derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $0.00 derived: sum of 2 quarters · filed 2020-02-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-06 | $0.00 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-10-23 | $0.00 derived: sum of 2 quarters · filed 2018-10-23 | $0.00 10-Q · filed 2018-10-23 | $0.00 derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2018-07-24 | $0.00 10-Q · filed 2018-07-24 | $0.00 derived: sum of 3 quarters · filed 2019-02-06 | $0.00 derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-24 | $0.00 derived: sum of 2 quarters · filed 2019-02-06 | $0.00 derived: sum of 3 quarters · filed 2019-02-06 | $0.00 derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $0.00 derived: sum of 2 quarters · filed 2019-02-06 | $0.00 derived: sum of 3 quarters · filed 2019-02-06 | $0.00 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-10-24 | $0.00 derived: sum of 2 quarters · filed 2017-10-24 | $0.00 10-Q · filed 2017-10-24 | $0.00 derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-07-25 | $0.00 10-Q · filed 2017-07-25 | $0.00 derived: sum of 3 quarters · filed 2018-02-01 | -$6.80M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-04-25 | $0.00 derived: sum of 2 quarters · filed 2018-02-01 | -$6.80M derived: sum of 3 quarters · filed 2018-02-01 | -$11.70M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$6.80M derived: sum of 2 quarters · filed 2018-02-01 | -$11.70M derived: sum of 3 quarters · filed 2018-02-01 | -$12.50M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | -$6.80M 10-Q · filed 2016-10-26 | -$6.83M 10-Q · filed 2015-10-21 | -$11.70M derived: sum of 2 quarters · filed 2016-10-26 | -$12.50M 10-Q · filed 2016-10-26 | -$12.55M 10-Q · filed 2015-10-21 | -$12.67M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | -$4.90M 10-Q · filed 2016-07-21 | -$4.88M 10-Q · filed 2015-07-24 | -$5.70M 10-Q · filed 2016-07-21 | -$5.71M 10-Q · filed 2015-07-24 | -$5.87M derived: sum of 3 quarters · filed 2017-02-02 | -$11.26M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | -$800.00K 10-Q · filed 2016-04-21 | -$834.00K 10-Q · filed 2015-04-24 | -$968.00K derived: sum of 2 quarters · filed 2017-02-02 | -$6.36M derived: sum of 3 quarters · filed 2017-02-02 | -$8.29M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$5.56M derived: sum of 2 quarters · filed 2017-02-02 | -$7.50M derived: sum of 3 quarters · filed 2017-02-02 | -$15.10M 10-K · filed 2017-02-02 | -$15.13M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$5.39M 10-Q · filed 2015-10-21 | -$7.33M derived: sum of 2 quarters · filed 2015-10-21 | -$14.93M 10-Q · filed 2015-10-21 | -$19.86M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$1.93M 10-Q · filed 2015-07-24 | -$9.54M 10-Q · filed 2015-07-24 | -$14.47M derived: sum of 3 quarters · filed 2016-02-03 | -$20.64M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | -$7.61M 10-Q · filed 2015-04-24 | -$12.54M derived: sum of 2 quarters · filed 2016-02-03 | -$18.70M derived: sum of 3 quarters · filed 2016-02-03 | -$20.99M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$11.10M derived: sum of 2 quarters · filed 2016-02-03 | -$13.39M derived: sum of 3 quarters · filed 2016-02-03 | -$17.20M 10-K · filed 2016-02-03 | -$17.22M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$6.17M 10-Q · filed 2014-10-22 | -$8.46M derived: sum of 2 quarters · filed 2014-10-22 | -$12.27M 10-Q · filed 2014-10-22 | -$15.02M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$2.29M 10-Q · filed 2014-07-23 | -$6.10M 10-Q · filed 2014-07-23 | -$8.85M derived: sum of 3 quarters · filed 2015-02-04 | -$10.11M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$3.81M 10-Q · filed 2014-04-23 | -$6.56M derived: sum of 2 quarters · filed 2015-02-04 | -$7.82M derived: sum of 3 quarters · filed 2015-02-04 | -$8.33M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$4.01M derived: sum of 2 quarters · filed 2015-02-04 | -$4.52M derived: sum of 3 quarters · filed 2015-02-04 | -$4.52M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$1.26M 10-Q · filed 2013-10-28 | -$1.77M derived: sum of 2 quarters · filed 2013-10-28 | -$1.77M 10-Q · filed 2013-10-28 | -$1.77M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$511.00K 10-Q · filed 2013-07-25 | -$511.00K 10-Q · filed 2013-07-25 | -$511.00K derived: sum of 3 quarters · filed 2014-02-06 | -$511.00K derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2013-04-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-06 | $0.00 derived: sum of 3 quarters · filed 2014-02-06 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $0.00 derived: sum of 2 quarters · filed 2014-02-06 | $0.00 10-K · filed 2014-02-06 | |||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-25 | $0.00 10-Q · filed 2012-10-25 | ||||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |